STAT+: Do GLP-1s work for Parkinson’s? A health tech startup pitches pharma on quick answers
STAT December 10, 2024
Koneksa’s pitch shows why some digital health startups are at the mercy of drug developers
NEW YORK — On the 77th floor of One World Trade Center, in an office with panoramic views of Manhattan, executives from pharma and biotech companies like Regeneron and Merck heard the pitch: Please help us study GLP-1s in Parkinson’s disease.
With the...